Morgan, M. R. (2009). Regulation of Innovation Under Follow-On Biologics Legislation: FDA Exclusivity As An Efficient Incentive Mechanism. Science and Technology Law Review, 11. https://doi.org/10.7916/stlr.v11i0.3846